Pacer Advisors
TECX

Pacer Advisors’s Tectonic Therapeutic TECX Stock Holding History

Pacer Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-193
Closed -$29K – 1570
2021
Q1 		$29K Buy
193
+93
+93% +$15.1K ﹤0.01% 1485
2020
Q4 		$17K Buy
100
+13
+15% +$2.31K ﹤0.01% 1490
2020
Q3 		$14K Buy
+87
New +$17.5K ﹤0.01% 1369

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pacer Advisors's TECX Position: Q2 2021 in Review

Pacer Advisors sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 193 shares — an estimated $29K sold.

Pacer Advisors first reported a position in TECX in Q3 2020 and held it in 3 quarters. The position peaked at $29K in Q1 2021. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.

  • Pacer Advisors reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 193 Tectonic Therapeutic shares in Q2 2021, an estimated $29K.
  • Pacer Advisors first reported a position in Tectonic Therapeutic in Q3 2020 and held it in 3 quarters.
  • Pacer Advisors's Tectonic Therapeutic position peaked at $29K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.